ARCHIVES

FDA Approves Lapatinib For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

Groups Push for CMS Coverage for LDCT Lung Screening

October 3, 2014

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.

June 11, 2004

Study Identifies Risk Factors To Predict Contralateral Cancer

February 27, 2009

Oncologists Tell Congress Community Cancer Practices Are Not Adequately Reimbursed

April 4, 2014

Full Clearinghouse To Meet; Members Reveal Interests In Evaluations

October 28, 1977